共查询到20条相似文献,搜索用时 15 毫秒
1.
Characterization of the Carbohydrate Moiety of Intestinal Mucin-Type Sialoglycoprotein Receptors for the K88ac Fimbrial Adhesin of Escherichia coli 总被引:2,自引:0,他引:2 下载免费PDF全文
Philippe A. Grange Alan K. Erickson Timothy J. Anderson David H. Francis 《Infection and immunity》1998,66(4):1613-1621
We have previously identified two mucin-type sialoglycoproteins from porcine intestinal epithelial cells with approximate molecular masses of 210 (intestinal mucin-type glycoprotein IMTGP-1) and 240 kDa (IMTGP-2) as receptors for the K88ab and K88ac fimbrial adhesins of Escherichia coli. These receptors are detected in intestinal brush border membrane preparations from pigs with adhesive phenotypes but not from pigs with nonadhesive phenotypes and are postulated to be important determinants of the susceptibility of pigs to K88ab+ and K88ac+ enterotoxigenic E. coli infections. Using exoglycosidase digestion studies, we have now determined that β-linked galactose is an important component in the recognition of IMTGP-1 and IMTGP-2 by the K88ac adhesin. In addition, we observed a differential distribution of the K88ac adhesin binding activity of IMTGP-1 and IMTGP-2 along the crypt-villus axis, suggesting that receptor activity is dependent on the maturation state of the intestinal epithelial cells. Brush borders from immature intestinal epithelial cells possessed the highest concentrations of IMTGP-1 and IMTGP-2 receptor activity, with a progressive decrease in receptor activity as the cells mature. To characterize the differences in the carbohydrate moieties of IMTGP-1 and IMTGP-2, we developed a procedure for purifying the receptors, using phenol extraction followed by serial lectin affinity chromatography. Carbohydrate compositional analysis of the purified receptors indicated that the carbohydrate moieties of IMTGP-1 and IMTGP-2 consist of both N- and O-glycans containing galactose, glucose, sialic acid, mannose, N-acetylgalactosamine, N-acetylglucosamine, and fucose. The major difference between the two receptors is that IMTGP-2 contains a higher percentage of monosaccharides (mannose and glucose) commonly found in N-glycans. 相似文献
2.
Detection of Clonal T-Cell Receptor γ Gene Rearrangements in Paraffin-Embedded Tissue by Polymerase Chain Reaction and Nonradioactive Single-Strand Conformational Polymorphism Analysis 下载免费PDF全文
Sabina Signoretti Michael Murphy Maria Giulia Cangi Pietro Puddu Marshall E. Kadin Massimo Loda 《The American journal of pathology》1999,154(1):67-75
The diagnosis of T-cell lymphoproliferative disorders, which frequently involve the skin and other extranodal sites, is often problematic because of the difficulty in establishing clonality in paraffin-embedded tissue. To this end, we developed a simple, nonradioactive method to detect T-cell receptor γ (TCR-γ) gene rearrangements by polymerase chain reaction single-strand conformational polymorphism (PCR-SSCP) in paraffin-embedded tissue. Jurkat and HSB-2 cell lines and peripheral blood samples from normal individuals were used as monoclonal and polyclonal controls, respectively. DNA was extracted from 24 biopsies of T-cell lymphomas, 12 biopsies of reactive lymphoid infiltrates, and 2 biopsies of primary cutaneous large B-cell lymphomas. Vγ1–8, Vγ9, Vγ10, Vγ11, and Jγ1/Jγ2 consensus primers were used for TCR-γ gene rearrangement amplification and PCR products were analyzed by nonradioactive SSCP. Monoclonal controls yielded a well-defined banded pattern, whereas all polyclonal T-cell controls showed a reproducible pattern of smears. We detected monoclonality in 20/21 (95%) T-cell lymphoma cases, whereas no dominant T-cell clones were found in any of the reactive lymphoid infiltrates or B-cell lymphomas. Sensitivity of 1–5% was demonstrated by serially diluting Jurkat cells in mononuclear blood cells from normal individuals. We conclude that nonradioactive PCR-SSCP for TCR-γ gene rearrangement analysis is a useful adjunct to routine histological and immunophenotypic methods in the diagnosis of T-cell lymphoproliferative disorders in paraffin-embedded tissue. 相似文献
3.
4.
Characterization of the Adhesin of Escherichia coli F18 Fimbriae 总被引:17,自引:0,他引:17
A. Smeds K. Hemmann M. Jakava-Viljanen S. Pelkonen H. Imberechts A. Palva 《Infection and immunity》2001,69(12):7941-7945
Previous research has suggested that the adhesin encoded by the F18 fimbrial operon in Escherichia coli is either the FedE or FedF protein. In this work, we show that anti-FedF antibodies, unlike anti-FedE serum, were able to inhibit E. coli adhesion to porcine enterocytes. Moreover, specific adhesion to enterocytes was shown with purified FedF-maltose binding protein. 相似文献
5.
F18 fimbriae and toxins produced by F18 fimbriae-carrying Escherichia coli (E. coli) strains are known virulence factors responsible for post-weaning diarrhea (PWD) and edema disease (ED). In this study, we showed that fliC isogenic mutants constructed in two reference wild-type F18 fimbriae (F18+) E. coli were markedly impaired in adherence in vitro cell models (p < 0.05). Flagella purified from F18+ E. coli could directly bind to cultured piglet epithelial cells and block adherence of F18+ E. coli to cells when pre-incubated. In addition, the F18+ E. coli fliC deletion mutants up-regulated the expression of type I fimbriae produced by F18+ E. coli strains. These results demonstrated that expression of flagella is essential for the adherence of F18+ E. coli in vitro. 相似文献
6.
Escherichia coli O18ac antigen: structure of the O-specific polysaccharide moiety. 总被引:2,自引:2,他引:2 下载免费PDF全文
The O-specific polysaccharide moiety (O18ac polysaccharide) of the O18ac antigen (lipopolysaccharide) from Escherichia coli 2980 (O18ac:K5:Fim+:H-) was isolated in pure form by degradation of the lipopolysaccharide and chromatography on Sephadex G-50. The primary structure of the O18ac polysaccharide was elucidated by composition, fragmentation procedures, methylation analysis, and nuclear magnetic resonance spectroscopy. The polysaccharide consists of repeating units of the pentasaccharide: (formula; see text) which are joined in the polymer by alpha-1,2 linkages. 相似文献
7.
Fekete PZ Schneider G Olasz F Blum-Oehler G Hacker JH Nagy B 《International journal of medical microbiology : IJMM》2003,293(4):287-298
Most virulence genes of enterotoxigenic Escherichia coli (ETEC) are located on plasmids. The gene for heat-stable enterotoxin I (sta) is part of the transposon Tn1681, and the heat-stable enterotoxin II (stb) gene was described to be part of the transposon Tn4521. In the studies presented here, we describe the linkage of the sta and stb genes on an approximately 10-kb fragment designated as toxin-specific locus (TSL). The TSL has been isolated from the 120-kb virulence plasmid pTC of the porcine ETEC strain 2173 that produces F18 fimbriae. The nucleotide sequence of the TSL fragment was determined. Sequences in the flanking regions of the sta gene indicated the presence of Tn1681, but--unexpectedly--flanking sequences of the neighbouring stb gene were completely different from those of Tn4521. The 10-kb TSL is part of a 40-kb fragment that contains the replication origin of pTC. This 40-kb fragment was mobilised into plasmid pACYC177 and the nucleotide sequence of the bordering fragments was determined. The 40-kb fragment was flanked by IS10 elements at both ends, indicating the existence of a new 40-kb pathogenicity island (PAI) in strain 2173. Several F4(K88)+ ETEC and F18+ ETEC as well as F18+ E. coli strains producing enterotoxins and verotoxin-2 (ETEC/VTEC) from weaned pigs of different geographical origin were tested for the flanking regions by PCR to see if they belong to the "Tn4521-like" or the "pTC-like" stb type. It turned out that the Tn4521-like stb-type was characteristic of F4(K88)+ ETEC, while the pTC-like stb type was present in most F18+ ETEC and F18+ ETEC/VTEC, although polymorphism was observed both in the K88 and F18 groups. These results suggest the existence and worldwide spread of a new plasmid-encoded pathogenicity island in porcine post weaning ETEC and ETEC/VTEC strains producing F18 fimbriae. 相似文献
8.
Demonstration of K88ac and K88ab antigens of Escherichia coli by means of immunoelectrophoresis and immunodiffusion. 下载免费PDF全文
Five strains of Escherichia coli were tested for the presence of the K88ac or K88ab antigens by immunoelectrophoresis and immunodiffusion. The K88ac antigen of 0A2 and Sojka Abbotstown gave an anodic line in the immunoelectrophoresis test and a line in immunodiffusion with homologous K88ac antisera. The K88ab antigens of 0G7, 0E68, and Moon 263 also gave anodic lines in immunoelectrophoresis, and were detectable by immunodiffusions. The 0 groups of these strains were also demonstrated by immunoelectrophoresis and immunodiffusion with homologous 0 antisera. Lack of complete inactivation at 100 degrees C of both the K88ac and K88ab antigens was noted in this study. 相似文献
9.
Mohapatra BR Broersma K Mazumder A 《International journal of medical microbiology : IJMM》2008,298(3-4):245-252
Determination of the non-point sources of fecal pollution is essential for the assessment of potential public health risk and development of appropriate management practices for prevention of further contamination. Repetitive extragenic palindromic-PCR coupled with (GTG)5 primer [(GTG)5-PCR] was performed on 573 Escherichia coli isolates obtained from the feces of poultry (chicken, duck and turkey) and free-living (Canada goose, hawk, magpie, seagull and songbird) birds to evaluate the efficacy of (GTG)5-PCR genomic fingerprinting in the prediction of the correct source of fecal pollution. A discriminant analysis with the jack-knife algorithm of (GTG)5-PCR DNA fingerprints revealed that 95%, 94.1%, 93.2%, 84.6%, 79.7%, 76.7%, 75.3% and 70.7% of magpie, hawk, turkey, seagull, Canada goose, chicken, duck and songbird fecal E. coli isolates classified into the correct host source, respectively. The results of this study indicate that (GTG)5-PCR can be considered to be a complementary molecular tool for the rapid determination of E. coli isolates identity and tracking the non-point sources of fecal pollution. 相似文献
10.
11.
Milita P. Matousek John G. Nedrud Witold Cieplak Jr. Clifford V. Harding 《Infection and immunity》1998,66(7):3480-3484
Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT) were found to inhibit intracellular antigen processing. Processing was not inhibited by mutant LT with attenuated ADP-ribosyltransferase activity, CT B or LT B subunit, which enhanced presentation of preexisting cell surface peptide-class II major histocompatibility complex complexes. Inhibition of antigen processing correlated with A subunit ADP-ribosyltransferase activity.Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT) are related ADP-ribosylating toxins with five identical B subunits that bind to cell surface ganglioside receptors and an enzymatically active A subunit that enters the cell and catalyzes the ADP-ribosylation of guanine nucleotide binding proteins of the adenylate cyclase complex, causing constitutive activation of adenylate cyclase and increased intracellular cyclic AMP (cAMP).LT and CT are potent mucosal adjuvants (7, 8, 12, 20, 22, 23, 29, 31–33). Some degree of A subunit enzymatic activity is required for oral adjuvant function (20, 23, 32, 33). While ADP-ribosyltransferase activity enhances adjuvanticity, it also confers toxicity. For an optimal adjuvant, reduced toxicity would be desirable, and mutant LT (6, 9–11, 15, 17, 21, 26, 34) and CT (5, 35) molecules have been constructed with altered A subunits, reduced ADP ribosylation activity, and reduced toxicity, yet with maintained adjuvant function (9–11, 13, 25, 26, 35). Mutation studies with LT revealed that residues at positions 7, 110, and 112 of LT A subunit (LTA) are important for ADP-ribosyltransferase activity (6, 21, 28), with Glu-112 providing a catalytic role. A conservative mutation (Asp to Glu) at position 112 produced a mutant toxin, rLT-E112D, with substantially reduced (<2% of wild type) but detectable ADP-ribosyltransferase activity (6).CT and LT affect many components of immune responses, including antigen presentation (3, 4, 18), with inhibitory as well as enhancing effects. We previously showed that CT enhances macrophage presentation of cell surface peptide-class II major histocompatibility complex (MHC-II) complexes to T cells but inhibits intracellular antigen processing (24). However, the effects of LT have not been similarly investigated. Furthermore, mutant LT molecules provide tools to determine the role of A subunit enzymatic activity in immunomodulation and toxicity.The present study was designed to investigate the effects of LT and mutant LT molecules on antigen processing and presentation by macrophages. In particular, we examined the effects of LT on the processing and presentation of a model antigen expressed in bacteria (a system to which LT has natural relevance) by using Escherichia coli strain HB101 expressing the Crl-HEL fusion protein (HB101.Crl-HEL) (27), which contains the HEL(48-61) epitope. LT, the mutant toxin rLT-E112D, and recombinant LTB (rLTB) (Table (Table1)1) were prepared as described previously (6, 15). rLTB was produced by using a vector encoding LTB and the A2 fragment of LT (LTA2), but subsequent chromatographic purification produced isolated rLTB, as revealed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis. Trypsin-cleaved LT was produced as described previously (15) and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Highly purified CT was purchased from List Biologicals (Campbell, Calif.). Recombinant CTB (rCTB) was a gift from Jan Holmgren (University of Gøteborg, Gøteborg, Sweden) and was prepared as described previously (30).
Open in a separate windowaEnzymatic activity is ADP-ribosyltransferase activity.
TABLE 1
Toxin composition and enzymatic activityToxin | Composition | Enzymatic activitya |
---|---|---|
LT | E. coli heat-labile enterotoxin (holotoxin) | Wild-type LT |
Trypsin-cleaved LT | Holotoxin with nicked, activated LTA | >Wild-type LT |
rLT-E112D | LT holotoxin with mutated A subunit | <2% of wild-type LT (6) |
rLTB | B subunit of LT | None |
CT | Cholera toxin (holotoxin) | Wild-type CT |
rCTB | B subunit of CT | None |
LT inhibits macrophage processing of HB101.Crl-HEL but not presentation of preexisting peptide–MHC-II complexes.
To determine the impact of LT on antigen processing, activated Listeria-elicited macrophages were obtained from CBA/J mice (H-2k) (16), plated at 2 × 105 cells/well in 96-well microtiter plates, washed to remove nonadherent cells, and incubated overnight with LT. The cells were then washed, incubated with viable E. coli HB101.Crl-HEL for 2 h to allow antigen processing, fixed in 1% paraformaldehyde, washed, and then incubated with 3A9 T hybridoma cells, as previously described (24). LT inhibited the processing of HB101.Crl-HEL for presentation to 3A9 cells at doses of 1 to 10 μg of LT per ml (data not shown; see below). Although cleavage of LTA into the A1 and A2 fragments may be required for LT enzymatic activity (14), we observed that trypsin-cleaved LT and intact LT had similar effects on antigen processing (although trypsin cleavage slightly enhanced the magnitude of inhibition). LT may be cleaved by cell-derived proteases during uptake into cells, making prior in vitro cleavage unnecessary (19). Subsequent studies were done with uncleaved LT at 1 μg/ml.In order to assess the stage of antigen processing and presentation that was affected by LT, macrophages were sequentially exposed to LT and antigen in various orders. In the first protocol, macrophages were incubated with LT prior to incubation with viable HB101.Crl-HEL. In the second protocol, macrophages were first incubated with HB101.Crl-HEL to allow unaltered bacterial antigen processing, production of peptide–MHC-II complexes, and expression of these complexes on the cell surface. The macrophages were then washed and incubated with or without LT. The inhibitory effects observed when the antigen incubation followed LT exposure (Fig. (Fig.1A)1A) were not observed when macrophages were first incubated with antigen and then exposed to LT (Fig. (Fig.1B).1B). These results indicate that LT inhibited an intracellular stage of bacterial antigen processing, prior to expression of peptide–MHC-II complexes on the cell surface, since the presentation of complexes that were previously expressed on the cell surface was not altered by LT. Open in a separate windowFIG. 1Overnight treatment of macrophages with LT inhibits intracellular processing of HB101.Crl-HEL but does not inhibit the presentation of preexisting surface peptide–MHC-II complexes. Macrophages were incubated with viable HB101.Crl-HEL for 2 h either after (A) or before (B) overnight treatment with LT (1 μg/ml). (A) Macrophages were treated with or without LT overnight, washed, incubated with HB101.Crl-HEL for 2 h at 37°C, fixed with 1% paraformaldehyde, and washed extensively. (B) Macrophages were incubated with HB101.Crl-HEL for 2 h at 37°C, washed, treated with or without LT overnight, fixed, and washed extensively. Antigen presentation was determined by incubation with HEL-specific 3A9 T hybridoma cells (105/well) for 20 to 24 h at 37°C, followed by a bioassay for interleukin 2 production (16). Interleukin 2-dependent CTLL-2 cells were incubated for 24 h at 37°C with supernatants collected from antigen presentation assays. The cells were then pulsed for 18 to 24 h with Alamar blue. Both reduced and oxidized forms of Alamar blue have high absorbance near 570 nm, whereas only the oxidized form has high absorbance near 600 nm. Production of the reduced form (a measure of cell growth and metabolic activity) can be measured by subtracting the optical density at 600 nm (OD600) from OD570 (2) or subtracting OD595 from OD550. All data points are presented as mean (OD550 − OD595) ± standard deviation for triplicate points.In addition, two other observations suggest that the inhibitory mechanism involved changes in intracellular antigen processing, as opposed to changes in the overall expression of MHC-II molecules or the ability of T cells to recognize peptide–MHC-II complexes that were expressed by the macrophages. First, treatment of macrophages with LT did not alter the expression of I-Ak at the cell surface, as determined by flow cytometry (data not shown). In addition, when macrophages were first treated with LT and then incubated with HEL(48-61) peptide, which does not require intracellular processing, presentation to 3A9 cells was not inhibited (data not shown). Thus, LT inhibited an intracellular stage of antigen processing and (within this time frame) did not affect the MHC-II expression or the presentation of peptide–MHC-II complexes on the surface of the cell.Inhibition of HB101.Crl-HEL processing by LT is not due to inhibition of antigen catabolism.
Additional studies assessed whether the inhibition of antigen processing by LT was due to a decrease in the ability of macrophages to internalize and catabolize bacteria and their antigens. Macrophages were incubated overnight with or without LT or CT. The ability of the macrophages to internalize and degrade 125I-labeled HB101.Crl-HEL was then assessed (Fig. (Fig.2).2). LT produced no consistent change in bacterial uptake and catabolism (minimal decreases were observed in some experiments), and CT produced only slight decreases in bacterial uptake and catabolism (Fig. (Fig.2).2). Thus, LT had little or no effect on bacterial uptake and catabolism, indicating that other aspects of the antigen-processing pathway were affected by LT. Open in a separate windowFIG. 2LT and CT do not inhibit macrophage catabolism of HB101.Crl-HEL. Macrophages (2 × 106 cells/well in 24-well plates) were incubated overnight with or without LT or CT (1 μg/ml). 125I-labeled HB101.Crl-HEL was centrifuged onto the macrophages at 2,500 × g for 10 min at 4°C. The plates were then incubated at either 4°C (negative control) or 37°C for 20 min, washed to remove extracellular bacteria, and then incubated for 2 h at either 4 or 37°C to allow for processing and catabolism of intracellular bacteria. High-molecular-weight proteins were precipitated from both the media and cell lysates (cells solubilized in 1% Triton X-100 in phosphate-buffered saline) with 10% trichloroacetic acid at 4°C. Bacterial catabolism was reflected by trichloroacetic acid-soluble radioactivity in the medium, shown here as a mean percentage of the total counts per minute in the well plus or minus the standard deviation of duplicate samples.LTA activity is necessary for inhibition of intracellular antigen processing, whereas LTB enhances the presentation of cell surface peptide–MHC-II complexes.
Macrophages that were treated overnight with rLTB or rCTB showed enhanced presentation of antigens that were subsequently added, in contrast to the inhibition seen with LT or CT holotoxins (Fig. (Fig.3A).3A). rLTB produced less enhancement than rCTB. In addition, rLTB and rCTB enhanced the presentation of synthetic HEL(48-61) peptide (data not shown), indicating that the enhancement involved increased recognition of peptide–MHC-II complexes present at the cell surface, as opposed to increased intracellular processing. The mechanism for this is unclear, but it does not involve increased MHC-II expression, which remained unchanged as determined by flow cytometry analysis (data not shown), and it may be caused by changes in cell surface adhesion or costimulator molecules (1). We conclude that the A subunit of LT is required for inhibition of antigen processing but not for enhancement of surface complex presentation. Open in a separate windowFIG. 3Ribosyltransferase activity of the A subunit is necessary for inhibition of antigen processing, whereas antigen presentation is enhanced by toxin preparations that lack A subunit enzymatic activity. Macrophages were treated overnight with or without the toxin preparations (1 μg/ml), washed, incubated with viable HB101.Crl-HEL for 2 h at 37°C, and fixed. Antigen presentation was determined by incubation with 3A9 T hybridoma cells for 20 to 24 h at 37°C.ADP-ribosyltransferase activity is necessary for the inhibition of antigen processing mediated by LT.
rLT-E112D, an LT holotoxin containing a point mutation in LTA, was previously shown to have <2% of wild-type ADP-ribosyltransferase activity (6). In contrast to wild-type LT, rLT-E112D did not inhibit antigen processing (Fig. (Fig.3B).3B). Thus, inhibition of antigen processing by LT requires significant levels of ADP-ribosylation activity. In fact, rLT-E112D produced a slight enhancement of antigen processing (Fig. (Fig.3B),3B), possibly due to the effects of the B subunit of this recombinant toxin in the absence of sufficient A subunit activity to produce inhibition.Effect of LT and mutant LT on intracellular cAMP levels.
Since the result of toxin-mediated ADP-ribosylation of Gs proteins is the accumulation of intracellular cAMP, the ability of LT and related molecules to elevate cAMP levels in macrophages was determined. CT caused transient increases of cAMP to high levels, with initial rises occurring within 0.5 h, a peak in cAMP levels at 1 to 2 h, and return of cAMP levels to normal levels by 19 h (Fig. (Fig.4).4). LT also increased intracellular cAMP but to lower levels and with slower kinetics of both onset (after 1 h) and decay (cAMP levels were still elevated at 19 h). Trypsin-cleaved LT increased cAMP more rapidly and to higher levels than LT, with levels approaching but not equaling those seen with CT within 0 to 2 h. This suggests that lack of prior cleavage of the A subunit may be important in the delayed kinetics and lower magnitude of the LT effect. Trypsin-cleaved LT, like LT, produced a longer-lasting elevation of cAMP than that seen with CT, with elevation persisting at 19 h. rLT-E112D produced little or no elevation of cAMP before 4 h but consistently produced low-level cAMP elevation at 19 h. As predicted, rLTB and rCTB produced no significant elevation of cAMP. Open in a separate windowFIG. 4Elevation of intracellular cAMP levels in macrophages after treatment with toxin preparations. Macrophages were treated overnight with the indicated toxin preparations (1 μg/ml), the cells were lysed in 66% ethanol, and cAMP levels were determined by using a TiterZyme dual-range cAMP enzyme immunoassay kit from PerSeptive Diagnostics (Cambridge, Mass.).In summary, the experiments reported here show that LT, like CT, inhibits intracellular processing of bacterial antigens for presentation by macrophages, although the extent of inhibition was less with LT than CT. In contrast, rLTB and rCTB had enhancing effects on antigen presentation. Furthermore, different recombinant and mutant LT molecules were used to explore the molecular mechanisms of these effects, particularly with regard to the role of LTA ribosyltransferase activity.Compared with CT, LT produced increases in cAMP characterized by lower magnitude, slower onset, and slower decay (Fig. (Fig.4),4), and LT may have lower specific ADP-ribosyltransferase activity than CT. This suggests that the ability of the toxins to inhibit antigen processing correlates with ribosyltransferase activity and their ability to induce cAMP, with greater inhibition of antigen processing being associated with either faster induction or higher levels of cAMP. The results with recombinant toxin molecules support this hypothesis, since rCTB and rLTB both failed to increase cAMP levels and did not inhibit antigen processing. Furthermore, rLT-E112D produced only a low elevation of cAMP levels and only at late time points, and this correlated with its inability to inhibit antigen processing. Trypsin-cleavage of LT produced accelerated and higher cAMP induction, which was accompanied by a slight enhancement of its ability to inhibit antigen processing (data not shown). Thus, ribosyltransferase-deficient molecules failed to inhibit antigen processing, and the inhibitory capacity of toxins generally correlated with their ability to induce cAMP. However, cAMP may not be the only signalling mechanism involved in the inhibition, since the toxins may have other mechanisms to transduce signals or mediate effects that act simultaneously with increases in cAMP. Thus, the increases in cAMP alone may not be sufficient to explain or cause inhibition of antigen processing.LT and CT inhibited an intracellular stage of antigen processing and did not inhibit the presentation of previously processed antigen or exogenous preprocessed synthetic peptide. Antigen uptake and catabolism were not inhibited by the toxins (Fig. (Fig.2),2), indicating that the effect occurred at a subsequent step in the pathway, possibly concerned with the supply of peptide-receptive MHC-II. The cell surface level of I-Ak molecules, as measured by flow cytometry, was not altered by overnight incubation of macrophages with LT, rLTB, rLT-E112D, CT, or rCTB (data not shown). However, it is still possible that LT caused a decrease in MHC-II synthesis that had not yet affected the overall plasma membrane expression level. Such a decrease in synthesis could decrease the availability of peptide-receptive molecules in intracellular compartments. Alternatively, LT may have altered intracellular trafficking of MHC-II, or H-2DM expression, localization, or function, in a manner to cause inhibition of antigen processing. Thus, the exact inhibitory mechanism remains to be elucidated, but it appears to involve decreased binding of antigen-derived peptides to intracellular MHC-II molecules.Although LT and CT have inhibitory effects on intracellular antigen-processing mechanisms, the overall net effect of in vivo administration of either toxin together with another antigen is enhancement of the immune response. One consideration is that the inhibitory effects are manifested only after long periods of incubation (e.g., 18 h), allowing significant processing of coadministered antigen to occur before the inhibitory phase. After production of peptide-MHC complexes on the plasma membrane, the ability of both LT and CT to enhance the presentation of surface complexes may contribute to the adjuvant effect. Thus, the inhibition of antigen processing by both CT and LT may be overcome by kinetic considerations and other strong enhancing effects in vivo. Furthermore, the use of mutant LT or CT molecules with diminished ADP-ribosyltransferase activity may decrease inhibitory and toxic effects, providing optimized adjuvant function. 相似文献12.
Predominance of the ac variant in K88-positive Escherichia coli isolates from swine. 总被引:2,自引:2,他引:2 下载免费PDF全文
R B Westerman K W Mills R M Phillips G W Fortner J M Greenwood 《Journal of clinical microbiology》1988,26(1):149-150
Monoclonal antibodies to K88ac and K88ab were used in enzyme-linked immunosorbent assays on Escherichia coli cultures known to produce K88 pili. A total of 415 K88-positive E. coli isolates from nine states were all found to be the K88ac variant. The cultures tested were isolated during the years 1976 to 1985. 相似文献
13.
Enterotoxigenic Escherichia coli (ETEC) strains expressing K88 (F4) fimbriae are the major cause of diarrhea in young pigs. Three antigenic variants of K88 fimbriae (K88ab, K88ac, and K88ad) have been identified among porcine ETEC strains. Each K88 fimbrial variant shows a unique pattern in binding to different receptors on porcine enterocytes. Such variant specificity in fimbrial binding is believed to be controlled by the major subunit (FaeG) of the K88 fimbriae, because the genes coding for the only other fimbrial subunit are identical among the three variants. Uniqueness in binding to host receptors may be responsible for differences in the virulence levels of porcine diarrhea disease caused by K88 ETEC strains. To better understand the relationships between the structure of FaeG proteins and fimbrial binding function, and perhaps virulence in disease, we constructed and expressed various K88ac/K88ad faeG gene chimeras and characterized the binding activity of each K88 chimeric fimbria. After verifying biosynthesis of the chimeric fimbriae, we examined their binding specificities in bacterial adherence assays by using porcine brush border vesicles that are specific to either the K88ac or K88ad fimbria. Results showed that each fimbria switched binding specificity to that of the reciprocal type when a peptide comprising amino acids 125 to 163 was exchanged with that of its counterpart. Substitutions of a single amino acid within this region negatively affected the binding capacity of each fimbria. These data indicate that the peptide including amino acids 125 to 163 of the FaeG subunit is essential for K88 variant-specific binding. 相似文献
14.
George Turabelidze Steven J. Lawrence Hongyu Gao Erica Sodergren George M. Weinstock Sahar Abubucker Todd Wylie Makedonka Mitreva Nurmohammad Shaikh Romesh Gautom Phillip I. Tarr 《Journal of clinical microbiology》2013,51(12):3950-3954
The current pathogen-typing methods have suboptimal sensitivities and specificities. DNA sequencing offers an opportunity to type pathogens with greater degrees of discrimination using single nucleotide polymorphisms (SNPs) than with pulsed-field gel electrophoresis (PFGE) and other methodologies. In a recent cluster of Escherichia coli O157:H7 infections attributed to salad bar exposures and romaine lettuce, a subset of cases denied exposure to either source, although PFGE and multiple-locus variable-number tandem-repeat analysis (MLVA) suggested that all isolates had the same recent progenitor. Interrogation of a preselected set of 3,442,673 nucleotides in backbone open reading frames (ORFs) identified only 1 or 2 single nucleotide differences in 3 of 12 isolates from the cases who denied exposure. The backbone DNAs of 9 of 9 and 3 of 3 cases who reported or were unsure about exposure, respectively, were isogenic. Backbone ORF SNP set sequencing offers pathogen differentiation capabilities that exceed those of PFGE and MLVA. 相似文献
15.
16.
Different pig phenotypes affect adherence of Escherichia coli to jejunal brush borders by K88ab, K88ac, or K88ad antigen. 总被引:8,自引:5,他引:3 下载免费PDF全文
At least five different porcine phenotypes were distinguished with the three serological variants of the K88 antigen in the brush border adhesion test. Pigs of one phenotype (A) are susceptible to adherence of all three variants, pigs of three phenotypes are susceptible to only two (B and C) or one (D) of the K88 variants, and pigs of one phenotype (E) are entirely resistant to adhesion of K88 antigen did not interfere with the adhesion of K88ab- or K88ac-positive Escherichia coli, whereas in most cases K88ab and K88ac antigen completely blocked the adhesion of K88ad-positive E. coli. Likewise, K88ab antigen blocked the adhesion of K88ac-producing E. coli to both type A and type B brush borders, and vice versa. 相似文献
17.
Characterization of F107 fimbriae of Escherichia coli 107/86, which causes edema disease in pigs, and nucleotide sequence of the F107 major fimbrial subunit gene, fedA. 总被引:9,自引:0,他引:9 下载免费PDF全文
H Imberechts H De Greve C Schlicker H Bouchet P Pohl G Charlier H Bertschinger P Wild J Vandekerckhove J Van Damme et al. 《Infection and immunity》1992,60(5):1963-1971
F107 fimbriae were isolated and purified from edema disease strain 107/86 of Escherichia coli. Plasmid pIH120 was constructed, which contains the gene cluster that codes for adhesive F107 fimbriae. The major fimbrial subunit gene, fedA, was sequenced. An open reading frame that codes for a protein with 170 amino acids, including a 21-amino-acid signal peptide, was found. The protein without the signal sequence has a calculated molecular mass of 15,099 Da. Construction of a nonsense mutation in the open reading frame of fedA abolished both fimbrial expression and the capacity to adhere to isolated porcine intestinal villi. In a screening of 28 reference edema disease strains and isolates from clinically ill piglets, fedA was detected in 24 cases (85.7%). In 20 (83.3%) of these 24 strains, fedA was found in association with Shiga-like toxin II variant genes, coding for the toxin that is characteristic for edema disease strains of E. coli. The fimbrial subunit gene was not detected in enterotoxigenic E. coli strains. Because of the capacity of E. coli HB101(pIH120) transformants to adhere to isolated porcine intestinal villi, the high prevalence of fedA in edema disease strains, and the high correlation with the Shiga-like toxin II variant toxin-encoding genes, we suggest that F107 fimbriae are an important virulence factor in edema disease strains of E. coli. 相似文献
18.
Enterotoxigenic Escherichia coli (ETEC) strains expressing K88 (F4) or F18 fimbriae and heat-labile (LT) and/or heat-stable (ST) toxins are the major cause of diarrhea in young pigs. Effective vaccines inducing antiadhesin (anti-K88 and anti-F18) and antitoxin (anti-LT and anti-ST) immunity would provide broad protection to young pigs against ETEC. In this study, we genetically fused nucleotides coding for peptides from K88ac major subunit FaeG, F18 minor subunit FedF, and LT toxoid (LT(192)) A2 and B subunits for a tripartite adhesin-adhesin-toxoid fusion (FaeG-FedF-LT(192)A2:B). This fusion was used for immunizations in mice and pigs to assess the induction of antiadhesin and antitoxin antibodies. In addition, protection by the elicited antiadhesin and antitoxin antibodies against a porcine ETEC strain was evaluated in a gnotobiotic piglet challenge model. The data showed that this FaeG-FedF-LT(192)A2:B fusion elicited anti-K88, anti-F18, and anti-LT antibodies in immunized mice and pigs. In addition, the anti-porcine antibodies elicited neutralized cholera toxin and inhibited adherence against both K88 and F18 fimbriae. Moreover, immunized piglets were protected when challenged with ETEC strain 30302 (K88ac/LT/STb) and did not develop clinical disease. In contrast, all control nonvaccinated piglets developed severe diarrhea and dehydration after being challenged with the same ETEC strain. This study clearly demonstrated that this FaeG-FedF-LT(192)A2:B fusion antigen elicited antibodies that neutralized LT toxin and inhibited the adherence of K88 and F18 fimbrial E. coli strains and that this fusion could serve as an antigen for vaccines against porcine ETEC diarrhea. In addition, the adhesin-toxoid fusion approach used in this study may provide important information for developing effective vaccines against human ETEC diarrhea. 相似文献
19.
Epitope analysis of the F4 (K88) fimbrial antigen complex of enterotoxigenic Escherichia coli by using monoclonal antibodies. 总被引:11,自引:0,他引:11 下载免费PDF全文
F G van Zijderveld J Anakotta R A Brouwers A M van Zijderveld D Bakker F K de Graaf 《Infection and immunity》1990,58(6):1870-1878
So far, three subtypes of the F4 (K88) fimbrial antigen of porcine enterotoxigenic Escherichia coli, F4ab, F4ac, and F4ad, have been distinguished by using polyclonal antisera in agglutination and precipitation tests. The a factor represents one or more common epitopes, whereas each of the b, c, and d factors represents one or more subtype-specific epitopes. We further characterized the F4 antigen complex by using a panel of 40 F4-specific monoclonal antibodies (MAbs). The specificity of all MAbs was proven by enzyme-linked immunosorbent assays, agglutination and radioimmunoprecipitation tests, and immunoelectron microscopy. The MAbs either reacted with all F4 subtypes, reacted with two subtypes, or were subtype specific. Epitope analysis by competition enzyme-linked immunosorbent assays revealed at least 11 epitope clusters on the F4 antigen complex, designated a1 to a7, b1, b2, c, and d. The following antigenic formulas were found for the F4 subtypes: F4ab, a1a2a3a4a5a6b1b2; F4ac, a1a2a3(a4)a5a6a7c; and F4ad, a1a2a3a4a7d. All MAbs were directed against conformational epitopes located on the 27,500-dalton major fimbrial subunits. Consequences for the replacement of polyclonal antisera by MAbs in diagnostic tests are discussed. 相似文献
20.
Differentiation of Burkholderia Species by PCR-Restriction Fragment Length Polymorphism Analysis of the 16S rRNA Gene and Application to Cystic Fibrosis Isolates 总被引:3,自引:0,他引:3 下载免费PDF全文
Christine Segonds Thierry Heulin Nicole Marty Gerard Chabanon 《Journal of clinical microbiology》1999,37(7):2201-2208
Burkholderia cepacia, which is an important pathogen in cystic fibrosis (CF) owing to the potential severity of the infections and the high transmissibility of some clones, has been recently shown to be a complex of five genomic groups, i.e., genomovars I, II (B. multivorans), III, and IV and B. vietnamiensis. B. gladioli is also involved, though rarely, in CF. Since standard laboratory procedures fail to provide an accurate identification of these organisms, we assessed the ability of restriction fragment length polymorphism (RFLP) analysis of amplified 16S ribosomal DNA (rDNA), with the combination of the patterns obtained with six endonucleases, to differentiate Burkholderia species. This method was applied to 16 type and reference strains of the genus Burkholderia and to 51 presumed B. cepacia clinical isolates, each representative of one clone previously determined by PCR ribotyping. The 12 Burkholderia type strains tested were differentiated, including B. cepacia, B. multivorans, B. vietnamiensis, and B. gladioli, but neither the genomovar I and III reference strains nor the genomovar IV reference strain and B. pyrrociniaT were distinguishable. CF clinical isolates were mainly distributed in RFLP group 2 (which includes B. multivoransT) and RFLP group 1 (which includes B. cepacia genomovar I and III reference strains, as well as nosocomial clinical isolates). Two of the five highly transmissible clones in French CF centers belonged to RFLP group 2, and three belonged to RFLP group 1. The remaining isolates either clustered with other Burkholderia species (B. cepacia genomovar IV or B. pyrrocinia, B. vietnamiensis, and B. gladioli) or harbored unique combinations of patterns. Thus, if further validated by hybridization studies, PCR-RFLP of 16S rDNA could be an interesting identification tool and contribute to a better evaluation of the respective clinical risks associated with each Burkholderia species or genomovar in patients with CF. 相似文献